IntelliPharmaCeutics International Inc

Company Snapshot
30 Worcester Road
Toronto, ON M9W 5X2
Canada
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 11
https://www.intellipharmaceutics.com
Please select from the dropdown
Company Financials

2019
2020
2021
Gross Profit
$3,447,448
$1,401,517
$0
Operating Income
($7,834,950)
($4,678,308)
($4,173,076)
Net Income
($8,084,646)
($3,390,965)
($5,145,155)
2019
Gross Profit
$3,447,448
Operating Income
($7,834,950)
Net Income
($8,084,646)
2020
Gross Profit
$1,401,517
Operating Income
($4,678,308)
Net Income
($3,390,965)
2021
Gross Profit
$0
Operating Income
($4,173,076)
Net Income
($5,145,155)
The above data on IntelliPharmaCeutics International Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Isa Odidi
Chairman of the Board and Chief Executive Officer
$350,306
$811,208
$13,950
$1,175,464
Isa Odidi
$1,175,464
Chairman of the Board and Chief Executive Officer
Amina Odidi
Director, President and Chief Operating Officer
$350,306
$811,208
$13,950
$1,175,464
Amina Odidi
$1,175,464
Director, President and Chief Operating Officer
Bahadur Madhani
Independent Director
$48,000
$0
$0
$48,000
Bahadur Madhani
$48,000
Independent Director
Kenneth Keirstead
Independent Director
$43,000
$0
$0
$43,000
Kenneth Keirstead
$43,000
Independent Director
Shawn Graham
Independent Director
$16,375
$0
$0
$16,375
Shawn Graham
$16,375
Independent Director
IntelliPharmaCeutics International Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2018. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us